Use of Sacral Neuromodulation in the Management of ... - SUNA
Use of Sacral Neuromodulation in the Management of ... - SUNA
Use of Sacral Neuromodulation in the Management of ... - SUNA
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Ur<strong>in</strong>ary Urgency-frequency and Ur<strong>in</strong>ary<br />
Urge Incont<strong>in</strong>ence<br />
1. Stewart WF, et al.<br />
Prevalence and burden <strong>of</strong><br />
overactive bladder <strong>in</strong> <strong>the</strong><br />
United States. World J Urol.<br />
2003:20:327-336.<br />
2. Garnett S, et al. The natural<br />
history <strong>of</strong> overactive bladder<br />
and detrusor overactivity: a<br />
review <strong>of</strong> evidence regard<strong>in</strong>g<br />
<strong>the</strong> long-term outcome <strong>of</strong> <strong>the</strong><br />
overactive bladder.<br />
J Urol. 2003;169:843.<br />
3. Haab F, et al. Persistence<br />
with antimuscar<strong>in</strong>ic<br />
<strong>the</strong>rapy <strong>in</strong> patients<br />
with overactive<br />
bladder. Int J Cl<strong>in</strong><br />
Pract. 2005;59(8):<br />
931-937. Ziment<br />
Market Research 2005.<br />
4. Medtronic Market Research<br />
1998<br />
US prevalence = 33.3 million 1<br />
7.3 million<br />
Women: 2.9 million<br />
Men: 1.1 million<br />
Women: 2.0 million<br />
Men: 0.8 million<br />
Total: 1.8 million<br />
Women: 1.3 million<br />
Men: 0.5 million<br />
16.5% <strong>of</strong> US<br />
population 1<br />
30% actively seek<strong>in</strong>g care<br />
(exclud<strong>in</strong>g men w/BPH<br />
~8.0 million) 2<br />
Patients who cannot tolerate<br />
pharmaco<strong>the</strong>rapy (~55%)<br />
4.0 million 3<br />
Patients with cont<strong>in</strong>ued symptoms<br />
actively seek<strong>in</strong>g fur<strong>the</strong>r treatment<br />
(~70%) 4<br />
2.8 million<br />
Potential patient candidates for<br />
SNS † (~65%)*<br />
Net Prevalence @ 1.8 million<br />
* Assum<strong>in</strong>g cl<strong>in</strong>ical exclusion <strong>of</strong> 20% & economic exclusion <strong>of</strong><br />
15%
Change language